References Pooyandjoo M, Nouhi M, Shab-Bidar S, Djafarian K, Olyaeemanesh A
Good candidates for GLP-1 weight loss therapy generally have a BMI of 30 or higher, or 27 or higher with weight-related health conditions like type 2 diabetes or hypertension
When breaks make sense vs continuous use The decision between GHK-Cu cycling with breaks versus continuous indefinite application depends on individual goals, budget constraints, treatment response patterns, and philosophical approach to skincare interventions, with different strategies suiting different user profiles and priorities creating no single optimal approach applicable universally
Timing Follow-up Marker Fasting glucose Why it matters IGF-related activity can affect glucose handling, so current glucose context matters
Discuss any medications or allergies with your provider
In proglucagon gene ( Gcg ) knockout mice, the GLP-1 receptor antagonist, exendin 9-39, led to impaired glucose tolerance when Gcg was reactivated in the pancreas, but not when intestinal Gcg was reactivated (115)